Rothschild Leelach, Goeller Jessica K, Voronov Polina, Barabanova Alexandra, Smith Peter
Department of Anesthesiology, Shriners Hospitals for Children, Chicago, Illinois.
Department of Anesthesiology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois.
Paediatr Anaesth. 2018 Nov;28(11):1050-1058. doi: 10.1111/pan.13504. Epub 2018 Oct 8.
Osteogenesis imperfecta is the collective term for a heterogeneous group of connective tissue syndromes characterized by bone fragility with multisystem involvement and perioperative implications.
Literature review of anesthetic management of patients with osteogenesis imperfecta revealed a paucity of data on the incidence of perioperative challenges. We sought to determine the rates of these challenges in our study cohort.
Data were collected in a specialty orthopedic hospital from 2008 to 2015 for 83 osteogenesis imperfecta patients undergoing 205 surgeries: 203 orthopedic surgeries and 2 mid-face reconstructive surgeries. Airway management, intravenous access, surgical blood loss, use of peripheral nerve blockade and/or neuraxial techniques, presence of perioperative fracture, and peak intraoperative temperature were evaluated and analyzed.
Difficult airway was encountered in 3/205 (1.5%) cases and perioperative fracture in 2/205 (1%) cases. Neuraxial anesthesia was attempted in 64/205 cases with an 87.5% success rate. All peripheral nerve block attempts (33/205 cases) were successful. Difficult intravenous catheter placement was noted in 8/205 (4%) cases. Estimated blood loss >10% of estimated blood volume was considered significant, and occurred in 35/205 (17%) cases. Significant blood loss occurred more often in severe osteogenesis imperfecta types: 18/76 (23.7%) in Type III and 11/65 (16.9%) in Type IV, whereas only 4/47 (8.5%) occurred in mild Type I. In our 205 case cohort, osteogenesis imperfecta Type III had 5.6 times the odds [(95% CI = 1.8-17.2) P = 0.003] of having an anesthetic complication as compared to osteogenesis imperfecta Type I.
Patients with osteogenesis imperfecta undergo frequent anesthetic exposures, but anesthetic challenges in our series were uncommon. Odds of challenges are greater in severe osteogenesis imperfecta Type III, with significant blood loss and difficulty placing intravenous catheters more likely encountered in the more severe types.
成骨不全是一组异质性结缔组织综合征的统称,其特征为骨脆性增加,伴有多系统受累及围手术期相关问题。
对成骨不全患者麻醉管理的文献综述显示,关于围手术期挑战发生率的数据较少。我们试图确定本研究队列中这些挑战的发生率。
2008年至2015年期间,在一家专科骨科医院收集了83例接受205例手术的成骨不全患者的数据:203例骨科手术和2例面部中部重建手术。对气道管理、静脉通路、手术失血、外周神经阻滞和/或神经轴技术的使用、围手术期骨折的发生情况以及术中最高体温进行了评估和分析。
205例中有3例(1.5%)遇到困难气道,2例(1%)发生围手术期骨折。205例中有64例尝试进行神经轴麻醉,成功率为87.5%。所有外周神经阻滞尝试(205例中的33例)均成功。205例中有8例(4%)静脉置管困难。估计失血量>估计血容量的10%被认为是显著失血,205例中有35例(17%)出现这种情况。严重成骨不全类型中显著失血更为常见:III型18/76(23.7%),IV型11/65(16.9%),而轻度I型仅4/47(8.5%)。在我们的205例队列中,与I型成骨不全相比,III型成骨不全发生麻醉并发症的几率高出5.6倍[(95%可信区间=1.8 - 17.2)P = 0.003]。
成骨不全患者经常接受麻醉,但我们系列中的麻醉挑战并不常见。严重的III型成骨不全发生挑战的几率更高,更严重类型更可能出现显著失血和静脉置管困难。